Companies that own Vical Inc.
Armistice Capital LLC
4,360,500
19.98%
2,060,500
0.46%
06/30/2018
BVF Partners LP
1,332,605
6.11%
-76,839
0.13%
06/30/2018
Perceptive Advisors LLC
1,142,858
5.24%
0
0.04%
06/30/2018
Renaissance Technologies LLC
877,729
4.01%
107,100
0%
06/30/2018
The Vanguard Group, Inc.
675,216
3.1%
133,895
0%
06/30/2018
BlackRock Fund Advisors
390,732
1.79%
62,144
0%
06/30/2018
Eventide Asset Management LLC
300,000
1.38%
-1,400,000
0.02%
06/30/2018
PanAgora Asset Management, Inc.
189,427
0.87%
182,553
0%
06/30/2018
Acadian Asset Management LLC
178,185
0.82%
30,706
0%
06/30/2018
Geode Capital Management LLC
111,688
0.51%
0
0%
06/30/2018
| Address |
10390 Pacific Center Court
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.vical.com |
| Updated |
07/08/2019 |
| Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. It has active development programs which comprises of ongoing phase 2 trial of HSV-2 therapeutic vaccine, VCL-HB01, to treat patients with symptomatic genital herpes infection; ongoing phase 2 trial of novel antifungal VL-2397, for the treatment of patients with invasive aspergillosis; and early stage development program of a novel treatment for chronic hepatitis B virus (CHB) infection based on its DNA and lipid-delivery technologies. The company was founded by Howard E. |
